Immune Regulation of CD36 in Cardiovascular Diseases
Immunology · 17.08.2026
DOI: 10.1111/imm.70167 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunology, online erschienen am 17.08.2026. Verfasst von Yujie Zha und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Die Arbeit nennt 99 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The scavenger receptor CD36 is a multifunctional membrane protein whose significance as a key node integrating metabolic and inflammatory pathways in cardiovascular pathophysiology is increasingly recognised. While its role in cellular fatty acid uptake is well‐established, a comprehensive and integrated elucidation of its specific immunoregulatory functions in cardiovascular diseases (CVDs) remains lacking. This review aims to clarify the specific immunoregulatory mechanisms of CD36 in prevalent cardiovascular conditions by examining its effects on common immune cells involved in these diseases. It details how CD36, functioning as both a lipid transporter and a signalling receptor, regulates the fate and function of key immune cells—for instance, influencing atherosclerosis through the modulation of macrophages. Furthermore, the article provides a critical assessment of the therapeutic potential of targeting CD36, analysing advances in the development of inhibitors and antibodies, as well as the paradoxical insights gained from studies on human CD36 deficiency. By synthesising current research, this review seeks to bridge important knowledge gaps and offer a reference for the development of novel immunometabolism‐based interventions for CVDs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- Department of General and Vascular Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zha, Y., Bao, L., Bi, C., Liu, B., Wei, Y., Sun, X., Pan, D., Liu, Y., Zhou, H., Gao, P., Wu, X., Dong, D., & Li, G. (2026). Immune Regulation of CD36 in Cardiovascular Diseases. Immunology. https://doi.org/10.1111/imm.70167
Vancouver
Zha Y, Bao L, Bi C, Liu B, Wei Y, Sun X, et al. Immune Regulation of CD36 in Cardiovascular Diseases. Immunology. 2026. doi:10.1111/imm.70167
BibTeX
@article{Zha2026,
author = {Zha, Yujie and Bao, Lili and Bi, Cong and Liu, Bingqi and Wei, Yuhua and Sun, Xiaofan and Pan, Dikang and Liu, Yujie and Zhou, Hua and Gao, Peixian and Wu, Xuejun and Dong, Dianning and Li, Gang},
title = {Immune Regulation of CD36 in Cardiovascular Diseases},
journal = {Immunology},
year = {2026},
doi = {10.1111/imm.70167}
}
EUVIMED